PRIMA US-Feasibility Study in Atrophic Dry AMD (PRIMA-FS-US)
Feasibility Study of Compensation for Blindness With the PRIMA System in Patients With Atrophic Dry Age Related Macular Degeneration
Sponsor: Science Corporation
Listed as NCT03392324, this NA trial focuses on Dry Age-related Macular Degeneration and remains ongoing. Sponsored by Science Corporation, it has been updated 15 times since 2018, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
15 versions recorded-
Dec 2024 — Present [monthly]
Active Not Recruiting NA
-
Sep 2024 — Dec 2024 [monthly]
Active Not Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting NA
-
Feb 2024 — Jul 2024 [monthly]
Active Not Recruiting NA
-
Apr 2023 — Feb 2024 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
▶ Show 10 earlier versions
-
Jul 2022 — Apr 2023 [monthly]
Recruiting NA
-
Feb 2021 — Jul 2022 [monthly]
Recruiting NA
-
Jan 2021 — Feb 2021 [monthly]
Recruiting NA
-
Sep 2020 — Jan 2021 [monthly]
Recruiting NA
-
Feb 2020 — Sep 2020 [monthly]
Recruiting NA
-
Dec 2019 — Feb 2020 [monthly]
Recruiting NA
-
Aug 2019 — Dec 2019 [monthly]
Recruiting NA
-
Jun 2019 — Aug 2019 [monthly]
Recruiting NA
-
Jun 2018 — Jun 2019 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Jan 2018 — Jun 2018 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Science Corporation
For direct contact, visit the study record on ClinicalTrials.gov .